Internal link ProQR Appoints John Maraganore, PhD, as Strategic Advisor to the Supervisory Board Março 07, 2022 at 12:00 PM UTC
Internal link ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results Fevereiro 24, 2022 at 12:00 PM UTC
Internal link ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10 Fevereiro 11, 2022 at 12:00 PM UTC
Internal link ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen Janeiro 04, 2022 at 12:00 PM UTC